Last update:

HIV & AIDS news

HIV & AIDS

Tuberculosis vulnerability of people with HIV: Viral protein implicated

According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 ...

HIV & AIDS

An HIV outbreak in Maine shows the risk of Trump's crackdown on homelessness and drug use

Penobscot County, Maine, is grappling with the largest HIV outbreak in the state's history. Home to Bangor, a city of roughly 32,000, the county has identified 28 new cases over nearly two years. That's seven times the typical ...

HIV & AIDS

How HIV uses T cells to hide in the gut

Antiretroviral treatments for HIV (human immunodeficiency virus) have been extremely successful in extending life expectancy and reducing transmission. But one major challenge has so far prevented researchers from developing ...

Genetics

Comorbidities in HIV: Big data study reveals molecular links

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine (CiiM) investigated this ...

HIV & AIDS

Setback in the fight against pediatric HIV

For more than 20 years, Harvard infectious disease specialist Roger Shapiro has fought HIV on the ground in Botswana, where the rate of infection exceeded 30% in some areas of the country in the 1990s.

Medications

Poorer countries granted access to HIV prevention drug

Lower-income countries will gain access to a "game-changing" HIV prevention drug with a new deal signed between US pharmaceutical giant Gilead and the Global Fund, the health financing group said Wednesday.

HIV & AIDS

HIV vaccine candidate's mysteries unlocked 20 years later

About two decades after first devising a new kind of vaccine, Oregon Health & Science University researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half of nonhuman primates—and ...

HIV & AIDS

Vaccine regimen fails to prevent HIV-1 infection in South Africa

(HealthDay)—A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue ...

HIV & AIDS

Researchers hunt for drugs that keep HIV latent

When the human immunodeficiency virus infects cells, it can either exploit the cells to start making more copies of itself or remain dormant—a phenomenon called latency. Keeping these reservoirs latent is a challenge. A ...

HIV & AIDS

Disappointment and hope from two HIV prevention trials

An antibody infusion being tested for preventing HIV does not seem to thwart most infections—but its success against certain strains of the virus suggests researchers are on the right track.

HIV & AIDS

HIV: An antidiabetic drug to reduce chronic inflammation

Metformin, a drug used to treat type-2 diabetes, could help reduce chronic inflammation in people living with HIV (PLWH) who are being treated with antiretroviral therapy (ART), according to researchers at the University ...

HIV & AIDS

Gilead, Merck team up to develop long-acting HIV drug

American pharmaceutical companies Gilead and Merck announced Monday they have partnered to develop a new HIV therapy that could see daily medications replaced by a treatment that can be taken at longer intervals.

Medical research

Increased weight gain with HIV-therapy TAF medication

Research team Inselspital and University of Bern found an above average weight gain associated with increase blood lipids after switching HIV-therapy from TDF to TAF. Additional individual counseling will be necessary to ...

Medications

Study: Increase in taking HIV meds using Amazon Prime model

Home delivery of HIV medicines in South Africa significantly increased viral suppression compared to those who received clinical care, according to a study by researchers at the University of Washington School of Medicine.

HIV & AIDS

HIV treatment helps prevent active TB

Antiretroviral treatment (ART) reduces the risk of developing active tuberculosis (TB) in people also infected with HIV-1, by dampening the activation of the body's immune response. These findings could help improve treatment ...

HIV & AIDS

Study examines incarceration among women at risk for HIV

Nearly half (46.7%) of women in the U.S. at risk for HIV have been incarcerated, according to a new study. The study is published in the peer-reviewed Journal of Women's Health. Click here to read the article now.

HIV & AIDS

Among Blacks, late-stage HIV diagnosis varies by rurality

(HealthDay)—The percentage of Black people with late-stage HIV diagnosis varies according to population area of residence and is higher in rural than urban and metropolitan areas, according to research published in the ...